Scientific Vita

Prof. Dr.

Sabrina Schreiner

Academic Education and University Degrees

Habilitation in Virology, University of Hamburg (mentor: Prof. Dr.Thomas Dobner), Germany
2006 - 2010
Ph.D. thesis, University of Hamburg, Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Germany, supervised by Prof. Dr. Thomas Dobner, University of Hamburg, Germany
2005 - 2006
Diploma work, Biology, University Hospital Regensburg, Institute for Microbiology and Hygiene, Germany, supervised by Prof. Thomas Dobner, University Hospital Regensburg, Germany
2001 - 2006
Study of Biology at Regensburg University, Germany


starting July 2023
W3 Professor, “Schwerpunkt Molekulare Virologie” Institute of Virology, University Hospital Freiburg, Freiburg, Germany
since Oct 2020-ongoing
W2 Professor, “Viral replication in Host Chromatin”, RESIST Excellence Cluster, Institute of Virology, Hannover Medical School (MHH), Hannover, Germany
Since 01/2015
Group leader at the Institute for Virology, TU Munich, Germany
2010 - 2014
Postdoc and group leader at the Department of Molecular Virology, Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Germany
Hofmann S, Mai J, Masser S, Groitl P, Hermann A, Brack-Werner R, Sternsdorf T and Schreiner S. 2019. ATO (Arsenic Trioxide) effects on PML nuclear bodies reveals antiviral intervention capacity. Advanced Science. 2020 Apr; 7(8): 1902130.
Wing P, Davenne, Wettengel J, Lai A, Chakraborty A, D’Arienzo V, Kramer C, Ko C, Harris J, Schreiner S, Higgs M, Parish J, Protzer U, Balfe P, Rehwinkel J, McKeating JA. 2019. A dual role for SAMHD1 in HBV cccDNA synthesis and RT-dependent particle genesis. Life Sci Alliance. 2(2):pii: e201900355.
Müncheberg S, Hay TR, Ip HW, Meyer T, Weiß C, Brenke J, Masser S, Hadian K, Dobner T, Schreiner S. 2018. E1B-55K mediated regulation of RNF4 STUbL promotes HAdV gene expression. J Virol. 92(13): pii: e00164-18.
Freudenberger N, Hay RT, Groitl P, Dobner T, Schreiner S. 2018. HAdV pV core protein is targeted by the host SUMOylation machinery to pursue essential viral functions. J Virol. 92(4): pii: e01451-17.
Schreiner S and Nassal M. 2017. A role for the host DNA damage response in hepatitis B virus cccDNA formation - and beyond? Review. Viruses. 9(5). pii: E125.
Wimmer P, Berscheminski J, Blanchette P, Groitl P, Branton PE, Hay RT, Dobner T Schreiner S. 2016. PML isoforms IV and V contribute to adenovirus-mediated oncogenic transformation by functionally inhibiting the tumor suppressor p53. Oncogene. 35(1):69-82.
Berscheminski J, Brun J, Speiseder T, Wimmer P, Ip WH, Terzic M, Dobner T, Schreiner S. 2015. Sp100A is a tumor suppressor that activates p53-dependent transcription and countercats E1A/E1B-55K-mediated transformation. Oncogene. 35(24):3178-89.
Berscheminski J, Wimmer P, Brun J, Ip WH, Horlacher T, Groitl P, Jaffray E, Hay RT, Dobner T, Schreiner S. 2014. Sp100 isoform-specific regulation of human Adenovirus type 5 (Ad5) gene expression. J Virol. 88(11):6076-92.
Schreiner S, Kinkley S, Bürck C, Mund A, Wimmer P, Schubert T, Groitl P, Dobner T. 2013. SPOC1-mediated antiviral host cell responses antagonized early in Human Adenovirus type 5 infection. PLoS Pathog. 9(11):e1003775.
Schreiner S, Bürck C, Glass M, Groitl P, Wimmer P, Kinkley S, Mund A, Everett RD and Dobner T. 2013. Control of human adenovirus type 5 gene expression by cellular Daxx/ATRX chromatin-associated complexes. Nucleic Acids Res. 41(6):3532-50.
(*co-first/co-last authorship)
Institute of Virology
Technische Universität München
Ingolstädter Landstrasse 1
85764 Neuherberg